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Reproductive Toxicity of Ethylene Glycol
Monoethyl Ether Tested by Continuous
Breeding of CD-i Mice
by James C. Lamb, IV,* Dushyant K. Gulati,t
Valerie S. Russell,t Leta Hommeltand Pritam S. Sabharwalt
The reproductive toxicity of ethylene glycol monoethyl ether (EGEE) was evaluated in the Fertility
Assessment by Continuous Breeding protocol. Both male and female CD-1 mice were given 0, 0.5, 1.0 or 2%
EGEE in the drinking water and were housed as breeding pairs continuously for 14 weeks. Significant
adverse effects on fertility were seen at 1 and 2% but not at 0.5%. After the continuous breeding phase of
this test was completed, treated males were housed with control females and treated females with control
males andfertility and reproduction were compared to the corresponding pairs ofcontrol male and control
female mice. Both males andfemales from the 1 and 2% groups were affected. Testicular atrophy, decreased
sperm motility and increased abnormal sperm were noted in the treated males, but no specific anomalies
were detected in the females.
Introduction
Ethylene glycol monoethyl ether (EGEE, 2-ethoxy-
ethanol) is a glycol ether with widely applicable solvent
properties. It is used in a variety of industrial
applications and in products used by consumers,
including paints and cleaners. NIOSH has estimated
that, between 1972 and 1974, about 400,000 workers
were exposed to EGEE (1). Previous studies have
demonstrated that EGEE exposure caused testicular
atrophy in males and birth defects in offspring exposed
to EGEE in utero (2,3). No studies have been found in
the published literature which describe fertility in
animals after EGEE exposure.
The National Toxicology Program has developed and
isvalidating a newreproductive toxicitytestingsystem.
This test system is designated Fertility Assessment by
Continuous Breeding (FACB). It is composed of up to
five interrelated tasks including: task 1, dose finding;
task 2, continuous breeding; task 3, identification ofthe
affected sex; task 4, offspring assessment; and task 5,
hormone measurements. The new system provides an
alternative to multigeneration studies and produces
similar comprehensive reproductive toxicity data at a
lower cost and in a shorter time frame.
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EGEE was studied for reproductive toxicity by using
the FACB protocol. Male and female CD-1 mice were
treated in task 2 with either 0, 0.5, 1.0 or 2% EGEE in
the drinking water throughout the course ofthe study.
The mice were monitored for effects on fertility, litter
size, offspring survival and pup weight. After the
continuous breeding portion ofthe study, the high dose
treated males were cohabited with control females and
high dose treated females with control males. The
mating performance in that crossover mating portion of
the study was used to determine whether males,
females or both sexes were affected by the chemical
exposure under the conditions of the study.
Materials and Methods
General Study Design
The flow chart for the NTP Fertility Assessment by
Continuous Breeding Protocol is shown in Figure 1.
Mice are quarantined for2 weeks priorto task 1 orfor 5
weeks prior to task 2. Task 1 utilizes a vehicle control
and five dose groups (8 males and 8 females per group)
and employs a 14-day repeated dose or continuous
administration schedule in order to ascertain the dose
levels to be administered in task 2. Task 1 is not
performedifadequatedataareavailableintheliterature
to select task 2 dose levels.
Task 2 is the continuous breeding phase of theLAMB ET AL.
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FIGURE 1. Flow chart for NTP fertility assessment by continuous
breeding protocol.
protocol. This phase employs a vehicle control group (40
males and 40 females) and three dose groups (20 males
and 20 females per group). The high dose may produce
some significant signs of toxicity, but should not
suppress body weight gain more than 10% compared to
controls and should allow 90% or greater survival in
male and female CD-1 mice. The mid-dose should
produce minimal or no toxic effects and the low dose
ideally is a no effect dose level. Eleven-week-old male
and female CD-1 mice are exposed to the chemical
during a 7-day premating period, after which they are
randomly paired (one male:one female) within each
dose group and cohabited for 98 days (14 weeks). New-
born litters are evaluated and immediately sacrificed.
Chemical exposure is continuous during the 98-day
cohabitation period and the 21-day segregation period
which follows. The final litters born to the control
and high dose pairs during the 21-day segregation
period may be weaned and evaluated for reproductive
performance intask4(OffspringAssessment). Chemical
exposure is continued for the offspring.
If significant effects on reproductive performance
(fertility or litter size) are found in task 2, then the
affected sex (male, female or both) is determined by
performing task 3. Task 2 high dose males are randomly
paired with control females, high dose females with
control males, and control males with control females
(20 pairs per group; all controls are assigned new
cagemates). The pairs are cohabited for 7 days, fewer if
acopulatory plugis observed. Consideringthe crossover
breeding design, the chemical treatment is not feasible
during the 7-day cohabitation. Reproductive perfor-
mance is determined by evaluation ofthe litters and by
effects on reproductive organs.
If minimal or no reproductive effects are noted in
task 2, then reproductive performance in the control
and high dose offspring from the final task 2 litters
is evaluated (task 4). Chemical exposure continues
throughout task 4. At 70 + 10 days of age, 20 high
dose male offspring are randomly paired with 20 high
dose female offspring and 20 control male offspring are
randomly paired with 20 control female offspring (one
pairper cage). Ifpossible, all high dose and control task
2 litters are sampled and sibling matings are avoided.
The pairs are cohabited for 7 days or fewer if a
copulatory plug is observed. Chemical administration is
continued during cohabitation. Reproductive perform-
ance is determined by evaluation of the litters. If
reproductive performance is adversely affected in the
high dose pairs, then task 3 can be carried out with
these same mice to determine whether one or both
sexes are affected. In this instance, the high dose
animals are bred to the opposite sex control animals.
Chemical
Ethylene glycol monoethyl ether (EGEE, CAS No.
110-80-5) was obtained from Union Carbide. Chemical
purity and dosing solution stability were analyzed by
the Midwest Research Institute under contract to the
National Toxicology Program. The chemical was 99.4%
pure with one major impurity which was 0.59% and
three minor impurities totaling 0.03%.
Dosage Formulation and Analysis
EGEE dosing solutions were prepared at 0.5, 1.0 and
2.0% (w/v). Dosing solutions were prepared fresh once
every 2 weeks and stored at room temperature under
yellow safe lights. The referee analyses were performed
every 6 weeks. Referee analyses indicated that dosage
solutions were within 99 to 108% ofthe intended dosage
concentrations.
Animals
COBS Crl:CD-1, (ICR)BR outbred albino mice (6
weeks of age) were purchased from Charles River
Breeding Laboratories, Inc., Kingston, NY. Duringthe
5-week quarantine period, two males and two females
were sacrificed and their sera evaluated for antibodies
against 11 mouse viruses (Microbiological Associates,
Inc., Bethesda, MD). All sera were negative for viral
antibodies. Furthermore, fecal samples were collected
from two randomly selected mice and examined for
86REPRODUCTIVE TOXICITY OF EGEE IN MICE
endoparasites. All results were negative. All study
animals were individually identified with metal ear tags
and assigned to control or treated groups using a
stratified randomization procedure based on body
weights.
Males and females were originally group housed by
sex in solid-bottom polycarbonate cages with stainless
steel wire lids, two per cage during quarantine and the
1-week premating period. Subsequently, the animals
were housed as breeding pairs or individually. Ab-Sorb-
Dri bedding (Laboratory Products, Inc., Garfield, NJ)
was used in all cages. Distilled water and Purina
certified ground rodent chow (#5002) were provided ad
libitum. Automatically controlled photoperiods were 14
hr light/10 hr dark (lights on 0700 to 2100 hours).
Temperature was maintained at 23 + 2°C and relative
humidity at 45 ± 25%. Cages were sanitized weekly by
using A33 detergent (Airwick Professional Products
Division, Secaucus, NJ) and 180°F water.
Clinical Signs, Body Weights and
Feed Consumption (Tasks 2 and 3)
Cage-side observations for clinical signs and litters
were made twice daily and the animals were given a
complete physical examination at the weekly weighing.
Body weights were determined weekly and at necropsy.
Water consumption was measured gravimetrically at
weekly intervals.
Fertility and Reproductive Performance
(Tasks 2 and 3)
During the 14-week cohabitation period and the
subsequent 3-week segregation period, the number and
proportion of fertile pairs and the number of litters
produced per breeding pair were determined. In
addition, for all litters in tasks 2 and for the one litter
per pair in task 3, the number and proportion of live
pups per litter, sex of live pups (males/total) per litter,
and mean body weight of live pups per litter were
determined. In particular, the live offspring were sexed,
counted, pooled and weighed by sex; dead pups were
counted, but not weighed or sexed. The pups were
immediately sacrificedbydecapitation, therebyallowing
the pairs to breed again at postpartum estrus. Breeding
pairs were defined as fertile if they produced at least
one pup (dead or alive).
Following delivery ofthe finallitterduringthe3-week
segregation period, the females in the 0.5% EGEE
group were sacrificed and discarded. The males in this
group were sacrificed and discarded at the conclusion of
the 14-week cohabitation period.
Since adverse effects on fertility and reproduction
were noted in the 1 and 2% EGEE groups (task 2), task
3 was performed in order to determine whether one or
both sexes were affected. On the day following the
3-week segregation period (task 2), the males exposed
to 2% EGEE were randomly paired with control
females, and control males were randomly paired with
females exposed to 2% EGEE. In addition, a third
group was formed by randomly pairing control males
with control females. Treatment with EGEE was
discontinued during the 1- to 7-day cohabitation period.
The females were checked twice daily for copulatory
plugs. Upon detection of a plug or after 7 days
(whichever occurred first), the male and female mice
were separated, housed individually, and treatment
resumed, (i.e., control or treated). The number and
proportion of positive matings were recorded. During
the 3-week period following the 1-week mating trial,
the number and proportion of fertile pairs, mean litter
size, sex, number and proportion oflive pups and mean
pup weight per litter were determined. Exfoliative
vaginal cells were sampled for five consecutive days
following task 3 from the females which were not
impregnated and/or did not deliver any pups animals to
determine ifthe females were exhibitingnormal estrous
cycles. The vaginal smears were stained with Toluidine
Blue 0 and cell types determined by light microscopy.
Five weeks after the one-week mating trial all male
and female breeding partners were weighed and then
asphyxiated with CO2 and bled by cardiac puncture.
Thelefttestis removed andweighed withthe epididymis
intact. Paired ventral prostate and paired seminal
vesicle/coagulating glands were removed and weighed
and fixed in 10% neutral buffered formalin.' The right
testis was separated from the epididymis and both
organs were weighed separately. The gonadswere fixed
in Bouin's fixative. The right caudal epididymis was
excised and weighed and sperm motility, cauda
epididymal sperm counts and percent abnormal sperm
were measured. For females, the intact reproductive
tract (ovaries, oviducts, uterus andupperhalfofvagina)
were excised and weighed. The reproductive tract was
preserved in neutral buffered 10% formalin. After
removing the top ofthe cranium, the entire head (males
and females) was placed in 10% formalin in order to fix
the brain and pituitary in situ. Subsequently, the brain
(cerebrum, cerebellum and medulla) and pituitary were
dissected from the cranium and weighed. The liver was
weighed and discarded.
Statistical Analysis
Statistical analyses of the data were performed by
Program Resources, Inc. (Research Triangle Park, NC)
using software written in APL and executed in an NIH
DEC 10 computer.
The chi-square test for homogeneity was used to test
for the joint equality of the proportion of fertile pairs,
theproportion offemaleswithcopulatoryplugs(positive
matings), and the proportion of fecund females among
treatment groups (4). Pairwise comparisons were
performed by using Fisher's exact test.
The number oflitters and the number oflive pups per
litterwere computed on a per fertile pair basis and then
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treatment group means determined. The groups were
compared overall using the chi-square approximation
to the Kruskal-Wallis test. Pairwise comparisons of
treatment groupsthenwere performedusingthenormal
approximation to the Mann-Whitney U test (4). The
analysis was carried out both on male and female data
combined, and separated by sex.
The number ofpups born alive over the total number
of pups produced by each pair was defined as the
proportion of live pups. The sex of live pups was
expressed as the proportion ofmale pups born alive out
ofthe total number oflive pups born to each fertile pair.
The sex ofthe pups born dead was not determined. The
chi-square approximation to the Kruskal-Wallis test
wasperformedtodeterminewhetherdifferences existed
among treatment groups for the proportion oflive pups
and the sex of live pups (males/total) per litter. The
normal approximation to the Mann-Whitney Utest was
used to make pairwise comparisons (4).
The Kruskal-Wallis and Mann-Whitney U tests also
were employed to test for among group and pairwise
differences in average live pup weight per litter. In
addition, an analysis of covariance was performed for
average live pup weight per litter with treatment group
as the classification variable and average number oflive
and dead pups per litter (task 2) or number of live and
dead pups per litter (task 3) as the covariate. Least-
squares treatment group means were generated from
the analysis of covariance and these were tested for
pairwise equality using a one-tailed t test (5). To control
for sex of live offspring both the nonparametric and
parametric analyses were performed separately for
both male and female data combined.
An analysis of variance was used to determine
whether the treated and combined control group body
weights differed significantly. The chi-square approxi-
mation to the Kruskal-Wallis test was employed to
Table 1. Ethylene glycol monoethyl ether: fertility of
pairs during continuous breeding.
Group No. fertile/no. cohabited Fertility index, %a
Control 40/40 100
0.5% 20/20 100
1.0% 18/20 90
2.0% 0/20* 0
aFertility index (%) = (No. fertile/no. cohabited) x 100.
*p < 0.001 as compared to controls.
determine whether differences existed between the
treated and combined control group organ weights.
The overall comparisons made with the chi-square
and F distributions were two-sided, while the pairwise
comparisons made with the normal and t distributions
were one-sided.
Results
No litters were found during the continuous breeding
phase of this study when the males and females
received 2% EGEE in the drinking water (task 2, Table
1). The effects on reproduction were observed at dosage
levels which did not produce detectable signs of clinical
toxicity or adverse body weight effects in the mice. Two
ofthe 20 pairs which received 1% EGEE did not deliver
any litters during this phase of the study. All pairs in
the control and 0.5% EGEE groups had at least one
litter in task 2.
There was a decrease in the mean number oflitters at
the 1% EGEE level (Table 2). The number of live pups
per litter was reduced and the proportion of pups born
alive, and mean live pup weight were also significantly
reduced in the 1% group compared to the controls. The
animals in the 0.5% treatment group did not seem to be
adversely affected by the EGEE exposure with respect
to these endpoints.
The continuous breeding portion ofthe protocol, task
2, generates a considerable amount of data on the
reproductive performance of the treated pairs, but it
cannot discriminate which sex (orsexes) may be affected
by the chemical exposure. Therefore task 2 is interfaced
with a crossover mating study, task 3, designed to
identify the sex affected by the chemical exposure. In
cases where significant effects on fertility are not
apparent (e.g., ethylene glycol, unpublished observa-
tions), the offspring from the treated pairs would be
studied for reproductive performance in task 4.
In this particular case both the 2% and the 1%
animals were tested in a crossover mating trial to
determine whether the males or females or both
sexes had compromised reproductive performance when
matched with control animals. At 2% EGEE in the
drinking water, the treated females had no fertile
matings when they were cohabited with control, known-
fertile male CD-1 mice, despite the fact that at least
seven of the pairs had copulated during the 1-week
cohabitation (Table 3). The males which were treated
Table 2. Ethylene glycol monoethyl ether: reproductive performance during continuous breeding.
EGEE dose level
Variables 0.0 0.5% 1.0% 2.0%
Litters per fertile paira 4.5 ± 0.1 4.8 ± 0.1 3.0 ± 0.3*
Live pups per littera 9.8 ± 0.5 9.3 ± 0.6 2.6 ± 0.4* --
Proportion of pups born alivea 0.94 ± 0.03 0.95 ± 0.02 0.50 ± 0.7*
Live pup weight, ga 1.63 ± 0.02 1.64 ± 0.02 1.59 ± 0.04*
aValues are group mean ± standard error.
*p < 0.05 as compared to controls.
88REPRODUCTIVE TOXICITY OF EGEE IN MICE
with 2% EGEE and were cohabited with control females
had significantly fewer fertile matings than the control
pairs (28% as compared to 85%, respectively) (Table 3)
and numberoflive pups perlitterwas slightly decreased
from 6.7 in the control group to 5.4 for the litters sired
by the treated males. There was no effect on the
number of dead pups per litter (Table 4).
The fertility of the mice from the middle dose group
(1% EGEE) was also tested by matching the treated
males and females with controls for a 1-week cohabi-
tation period. The standard protocol does not call for
this extratesting ofthe second dose level, and generally
there are not enough animals to accommodate this
additional test. In this case, however, control mice were
reused afterthe 2% EGEE crossover matinghad ended,
and the controls, the 1% group and 2% group mice were
all necropsied after the second crossover mating study.
This approach allowed us to study fertility and repro-
duction in the intermediate dose level. There was a
decrease, though not statistically significant, in the
percent fertile matings for both the treated males
cohabited with control females (44%) and the treated
females cohabited with control males (53%) compared to
the control pairs (78%, Table 5). The number of live
pups per litter was slightly lower in the treated female
x control male group than in the control female x
control male group; pup weight also seemed to be
decreased inthattreated group. Significant effects were
not demonstrated in the mid-dose treated male x con-
trol female mating (Table 6).
Since there were significant effects on fertility and
reproduction in both treated males and females, all
animals were necropsied and reproductive tract and
gonadal tissues were weighed and examined for gross
and histological effects. EGEE was related to profound
dose-related decreases in sperm motility and increases
Table 3. Ethylene glycol monoethyl ether: fertility in crossover
mating study (high dose, 2%).
Control d x Control d x High dose d x
control 9 high dose 9 control 9
No. fertile 17 0 5
No. cohabited 20 15 18
Fertility
index (%) 85 0* 28*
*p < 0.05
Table 5. Ethylene glycol monoethyl ether: fertility in crossover
mating study (middle dose, 1%).
Control d x Control d x Mid dose d x
control Y mid dose Y control 9
No. fertile 14 10 8
No. cohabited 18 19 18
Fertility
index, % 78 53 44
in the percent of morphologically abnormal sperm
(Table 7). Cauda epididymis weight and cauda epididy-
mal sperm counts were reduced but the pairwise
comparisons were not statistically significant. TIeat-
ment-related lesions were identified in the testis, in-
cluding decreased testis weight and decreased sper-
matogenesis. The dose-related decrease in spermato-
genesis conformed with findings of testicular atrophy.
No gross or microscopic lesions were significantly
increased in the female mice.
Discussion
The findings from the continuous breeding phase of
these investigations indicated that EGEE caused a
profound effect on reproductive function in CD-1 mice
both at the 1 and 2% dose levels in the drinking water.
The design of the task 2 protocol is such that the
complete absence of fertile matings in the breeding
pairs treated with 2% EGEE could not be attributed
to effects on either sex to the exclusion of the other,
since both male and female mice received the same
concentration of EGEE in the drinking water.
Therefore, the crossover mating trial, task 3, was
performed to determine whether both sexes were
affected by EGEE ingestion or if one sex was sig-
nificantly more susceptible to the chemical toxicity.
The results ofthe crossover mating trial indicated that
EGEE did not affect reproduction in one sex, to the
exclusion of affecting the other. At 2% EGEE, the
females had no fertile matings while the males had 28%
fertile matings. Although it seems that the female was
more susceptible to the effects of EGEE than the male
under the same exposure conditions, the relative toxic-
ity is certainly a minimal distinction where both were
significantly affected by the chemical at similar dosages
Table 4. Ethylene glycol monoethyl ether: reproductive performance during crossover mating study (high dose, 2%).
Control d x Control d x High dose d x
control 9 high dose 9 control 9
Live pups per littera 6.7 ± 0.8 b 5.4 + 1.8
Dead pups per littera 0.1 ± 0.1 0
Live pup weight, ga 1.73 1.76
aValues are mean ± standard error.
bSeven vaginal plugs detected, but no fertile matings.
*p < 0.05.
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Table 6. Ethylene glycol monoethyl ether: reproductive performance during crossover mating study (middle dose, 1%).
Control 6 x Control 6 x Mid dose d x
control Y mid dose Y control Y
Live pups per litter 5.7 ± 1.2 4.2 ± 0.9* 5.1 ± 1.2
Dead pups per litter 0.3 ± 0.2 0.8 ± 0.4 0.4 ± 0.3
Live pup weight, g 1.69 1.59 1.62
*p < 0.05.
Table 7. Ethylene glycol monoethyl ether: sperm assessment in treated mice.
EGEE dose levels
Control 1% 2%
Sperm/mg epididymisa b 729 ± 51 633 ± 66 593 ± 61
Percent motilea 68± 4 64± 4 42 ± 8*
Percent abnormala 3.3 ± 1.0 8.2± 1.6* 43 ± 8*
Testis weight, mga 136 4 121± 5 88 ± 7
Epididymal weight, mga 62 1 62 ± 2 51 ± 2
Caudal weight, mga 22.4 1 20.1± 1 19.4 ± 1
aValues are mean and standard error.
bMillion sperm per gram cauda epididymal tissue.
*p < 0.05 compared to controls.
and the no observed effect level for both sexes seemed
to be about 0.5% in the drinking water.
The results which have been described from this new
testing system are consisteqtt with previous investiga-
tions on the male reproductive toxicity of EGEE. For
example, testicular atrophy has been observed in male
mice exposed to EGEE (2). In that study, male mice
received ethylene glycol, EGEE orfive other monoalkyl
glycol ethers at levels from 62.5 to 4000 mg/kg/day by
gavage 5 days per week for 5 weeks. That study showed
that EGEE was associated with a significant decrease
in testis weight at a daily dose level of 1000 mg/kg but
accessory sex gland weights (seminal vesicles and
coagulating glands) were not affected by EGEE. Our
current study has also demonstrated that testis weight
was decreased by EGEE. EGEE has been associated
with testicular toxicity in laboratory animals in several
studies, one ofwhich dates backto 1942 (6). In addition,
we showed for the first time that fertility was dramati-
cally suppressed and sperm head abnormalities in-
creased in EGEE-treated male mice. The drinking
water consumption data and mean body weight data
indicated thatthe male mice which had 1% EGEE inthe
water received about 1500 mg EGEE/kg per day and
the mice receiving 2% EGEE in the water received
about 2600 mg EGEE/kg per day. Water consumption
was reduced in the 2% dose group mice without any
significant loss in body weight.
The effects ofEGEE on female mice might be related
to embryotoxicity, fetotoxicity or to a direct antifertility
effect of EGEE. The teratogenicity ofEGEE has been
demonstrated in rats and rabbits byinhalation exposure
(7) and rats afterdermal exposure (3). However, Andrew
et al. (7) detected no adverse effect on fertility offemale
rats exposed to EGEE by inhalation for 3 weeks.
There was evidence of a drop in offspring survival,
and a decrease in fertile matings was detected in the
EGEE-treated females. The majority of studies on the
toxicity of glycol ethers in females published to date
have involved gestational exposure to the compounds
(6). Those studies clearly demonstrated the teratogenic
potential ofthese compounds. In ourinvestigations, the
female mice that received 2% EGEE never delivered a
single offspring, alive or dead. The females receiving
1% had fewer live pups per litter. The teratogenicity of
EGEE may be responsible for the decreased pup
survival, but the decreased fertility in the female mice
could be related to gonadal, endocrine or reproductive
tract toxicity. These aspects of EGEE toxicity will be
addressed in later studies.
These investigations were performed under contract with the
National Toxicology Program and the National Institute of
Environmental Health Sciences (Contract No. N01-ES-2-5013 and
No. N01-ES-95615). We appreciate the assistance of Dr. B. Hardin
(NIOSH), Dr. C. W Jameson (NIEHS), Dr. C. A. Kimmel (NCTR)
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